No Additional Issue Sample Clauses

No Additional Issue. Except as disclosed in the Information Circular, as of the date hereof, no person or entity has any agreement, warrant, or option, or any right capable of becoming an agreement, warrant or option, for the purchase of any unissued shares in the capital of Bayswater, except for up to an aggregate of 3,055,000 common shares issuable on exercise of outstanding stock options previously granted to directors, officers, employees and consultants of Bayswater and up to an aggregate of 8,638,469 Bayswater Shares issuable on exercise of outstanding warrants previously issued pursuant to private placements. Except as disclosed herein or in the Information Circular, no person has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase or issue of or conversion into any of the unissued shares of Bayswater or any unissued securities of Bayswater.
AutoNDA by SimpleDocs
No Additional Issue. As of the date hereof, no person or entity has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase of any unissued shares in the capital of Northern, or to require or permit Northern to purchase, redeem, or otherwise acquire any Northern Shares, except as described hereto in Schedule “B”.
No Additional Issue. As of the date hereof, no person or entity has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase of any unissued shares in the capital of Prophecy or any Prophecy Subsidiary, or to require Prophecy to purchase, redeem, or otherwise acquire any Prophecy Shares, except as described hereto in Schedule “C” or as contemplated by this Agreement.
No Additional Issue. As of the date hereof, no person or entity has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase of any unissued shares in the capital of Ursa, or to require or permit Ursa to purchase, redeem, or otherwise acquire any Ursa Shares, except as set forth in in Section 3.1(c) of the Ursa Disclosure Schedule or as contemplated by this Agreement. No Person has any pre-emptive right or right of first refusal in respect of the allotment and issuance of any unissued Ursa Shares, preferred shares or any other securities of Ursa.
No Additional Issue. As of the date hereof, no person or entity has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase of any unissued shares in the capital of Prophecy or any Prophecy Subsidiary, or to require or permit Prophecy to purchase, redeem, or otherwise acquire any Prophecy Shares, except as described hereto in Section 3.2(c) of the Prophecy Disclosure Schedule or as contemplated by this Agreement. No Person has any pre-emptive right or right of first refusal in respect of the allotment and issuance of any unissued Prophecy Shares, preferred shares or any other securities of Prophecy.‌
No Additional Issue. Except as disclosed in the Information Circular, as of the date hereof, no person or entity has any agreement, warrant, or option, or any right capable of becoming an agreement, warrant or option, for the purchase of any unissued shares in the capital of Pathfinder, except for up to an aggregate of 1,905,000 Pathfinder Shares issuable on exercise of outstanding stock options previously granted to directors, officers, consultants and employees of Pathfinder and up to an aggregate of 1,189,666 Pathfinder Shares issuable on exercise of outstanding warrants previously issued pursuant to private placements. Except as disclosed herein or in the Information Circular, no person has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase or issue of or conversion into any of the unissued shares of Pathfinder or any unissued securities of Pathfinder.
No Additional Issue. Except as disclosed in the Information Circular, as of the date hereof, no person or entity has any agreement, warrant, or option, or any right capable of becoming an agreement, warrant or option, for the purchase of any unissued shares in the capital of Xxxxxxx, except for up to an aggregate of 1,753,432 Xxxxxxx Shares (on a pre-Share Split basis) issuable on exercise of outstanding stock options previously granted to directors, officers, consultants and employees of Xxxxxxx, up to an aggregate of 281,548 Xxxxxxx Shares (on a pre-Share Split basis) issuable on exercise of outstanding warrants previously issued pursuant to private placements, and up to an aggregate of 6,000 Xxxxxxx Shares (on a pre-Share Split basis) issuable upon the exercise of agent’s options. Except as disclosed herein or in the Information Circular, no person has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase or issue of or conversion into any of the unissued shares of Xxxxxxx or any unissued securities of Xxxxxxx.
AutoNDA by SimpleDocs
No Additional Issue. Except as disclosed in the Information Circular, as of the date hereof, no person or entity has any agreement, warrant, or option, or any right capable of becoming an agreement, warrant or option, for the purchase of any unissued shares in the capital of NCA, except for up to an aggregate of 2,515,000 NCA Shares issuable on exercise of outstanding stock options previously granted to directors, officers, consultants and employees of NCA and up to an aggregate of 450,000 NCA Shares issuable on exercise of outstanding warrants previously issued pursuant to private placements. Except as disclosed herein or in the Information Circular, no person has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase or issue of or conversion into any of the unissued shares of NCA or any unissued securities of NCA.
No Additional Issue. As of the date hereof, no person or entity has any agreement, option, understanding or commitment (including convertible securities, warrants or convertible obligations of any nature), for the purchase of any unissued shares in the capital of Spinco, or to require Spinco to purchase, redeem, or otherwise acquire any Spinco Shares; and

Related to No Additional Issue

  • Additional Issues Within [**] days after the receipt of the Arbitration Request, the other Party may, by written notice, add additional issues for resolution in a statement of counter-issues.

  • Additional Issuances There are no outstanding agreements or preemptive or similar rights affecting the Company's common stock or equity and no outstanding rights, warrants or options to acquire, or instruments convertible into or exchangeable for, or agreements or understandings with respect to the sale or issuance of any shares of common stock or equity of the Company or other equity interest in any of the subsidiaries of the Company, except as described in the Reports or Other Written Information.

  • Original Issue The Notes may, upon execution of this Thirteenth Supplemental Indenture, be executed by the Company and delivered by the Company and the Parent Guarantor to the Trustee for authentication, and the Trustee shall, upon Company order, authenticate and deliver such Notes as in such Company order provided.

  • Additional Issuing Banks From time to time, the Borrower may by notice to the Administrative Agent designate any Lender (in addition to the initial Issuing Bank) each of which agrees (in its sole discretion) to act in such capacity and is reasonably satisfactory to the Administrative Agent as an Issuing Bank. Each such additional Issuing Bank shall execute a counterpart of this Agreement upon the approval of the Administrative Agent (which approval shall not be unreasonably withheld) and shall thereafter be an Issuing Bank hereunder for all purposes.

  • Additional Issuer Information Prior to the completion of the placement of the Securities by the Initial Purchasers with the Subsequent Purchasers, the Company shall file, on a timely basis, with the Commission and the NYSE all reports and documents required to be filed under Section 13 or 15 of the Exchange Act. Additionally, at any time when the Company is not subject to Section 13 or 15 of the Exchange Act, for the benefit of holders and beneficial owners from time to time of the Securities, the Company shall furnish, at its expense, upon request, to holders and beneficial owners of Securities and prospective purchasers of Securities information (“Additional Issuer Information”) satisfying the requirements of Rule 144A(d).

  • Original Issue Discount If any of the Securities is an Original Issue Discount Security, the Company shall file with the Trustee promptly at the end of each calendar year (1) a written notice specifying the amount of original issue discount (including daily rates and accrual periods) accrued on such Outstanding Original Issue Discount Securities as of the end of such year and (2) such other specific information relating to such original issue discount as may then be relevant under the Internal Revenue Code.

  • Additional Issuing Lenders The Borrower may, at any time and from time to time with the consent of the Administrative Agent (which consent shall not be unreasonably withheld) and such Lender, designate one or more additional Lenders to act as an issuing bank under the terms of this Agreement. Any Lender designated as an issuing bank pursuant to this paragraph shall be deemed to be an “Issuing Lender” (in addition to being a Lender) in respect of Letters of Credit issued or to be issued by such Lender, and, with respect to such Letters of Credit, such term shall thereafter apply to the other Issuing Lender and such Lender.

  • Additional Items The Insurer has received such other documents, instruments, approvals or opinions in form and substance reasonably satisfactory to the Insurer as are reasonably requested by the Insurer, including evidence reasonably satisfactory to the Insurer that the conditions precedent, if any, in the Transaction Documents have been satisfied.

  • Original Issue Discount Security 13 Outstanding...................................................13

  • Additional Issuances of Notes Subject to clauses (ii), (iii), (iv) and (v) of Section 2.02 and Section 2.03 of the Indenture Supplement, the Issuer may issue additional Class A(2018-2) Notes, so long as the following conditions precedent are satisfied:

Time is Money Join Law Insider Premium to draft better contracts faster.